Helicoid Peripapillary Chorioretinal Degeneration Complicated by Choroidal Neovascularization. Issue 2 (March 2016)

• Record Type: Journal Article
• Authors: Triantafylla, Magdalini; Panos, Georgios D.; Dardabounis, Doukas; Nanos, Panagiotis; Konstantinidis, Aristeidis
• Is Part Of: European journal of ophthalmology. Volume 26:Issue 2(2016)
• Page Start: e30
• Page End: e31
• Publication Date: 2016-03
• Subjects: Choroidal neovascularization -- Helicoid peripapillary chorioretinal degeneration -- Ranibizumab; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; 617.7005
• DOI: 10.5301/ejo.5000695
• Languages: English
• ISSNs: 1120-6721

Abstract

Purpose: Helicoid peripapillary chorioretinal degeneration (HPCD) is a hereditary disease of the fundus that is characterized by atrophic chorioretinal areas that appear early in life and expand gradually from the optic disc towards the macula and the periphery. Methods: We describe the case of an elderly man with a known diagnosis of HPCD who developed choroidal neovascular membrane (CNV) in both eyes during the course of the disease. Results: The patient was treated with intravitreal injection of ranibizumab, to which he had excellent response. The CNV subsided with 2 injections in the right eye and 1 in the left. Two years after the initial diagnosis of CNV in the right eye, visual acuity was 5/10 OD and 9/10 OS. Conclusions: Helicoid peripapillary chorioretinal degeneration is rarely complicated by CNV as the fundus lacks the trigger factors that would sustain this process. Although rare, HPCD complicated by CNV can be seen bilaterally, but responds well to few ranibizumab injections.